Direct Assessment of Combination Drug Efficacy in Individual Patients Using a New Sensitive Single Cell Imaging Screening Platform
Tania Vu,
Associate Professor,
Oregon Health and Science University
I describe a new single cell imaging platform that enables validation and value for identifying the effectiveness of single agent/drug combinations in individual cancer patient samples. I will show the value of this functional cytometry platform for identifying drug target effectiveness, and overall drug efficacy and resistance in individuals.
|
|
